NCT01461551View on ClinicalTrials.gov

Anesthesia and Lymphocytes Apoptosis

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

October 31, 2014

Conditions
Anesthesia
Interventions
DRUG

Sevoflurane

anesthesia was maintained with sevoflurane (end-tidal concentration 1.0-1.5 minimum alveolar concentration)

DRUG

Propofol

anesthesia was maintained with propofol (2-4 μg/ml via target-controlled infusion)

DRUG

combine of sevoflurane and propofol

anesthesia was maintained with a combine of propofol (1 μg/ml via target-controlled infusion) and sevoflurane (end-tidal concentration 0.7-1.0 minimum alveolar concentration)

Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT01461551 - Anesthesia and Lymphocytes Apoptosis | Biotech Hunter | Biotech Hunter